A Multi-Center, Randomized, Double-Blind, 12 Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RO5285119 in Individuals with Autism Spectrum Disorders (ASD)
Clinical Trial Grant
Administered By
Psychiatry, Child & Family Mental Health & Community Psychiatry
Awarded By
Roche Biomedical Laboratories
Start Date
January 26, 2016
End Date
February 28, 2018
Administered By
Psychiatry, Child & Family Mental Health & Community Psychiatry
Awarded By
Roche Biomedical Laboratories
Start Date
January 26, 2016
End Date
February 28, 2018